Related Experiment Video
Updated: Jan 21, 2026
14:01
Optimization of the Cuff Technique for Murine Heart Transplantation
Published on: June 26, 2020
10.1K
Multimorbidity and medication complexity: New challenges in heart transplantation
Mar Gomis-Pastor1,2, Eulalia Roig Mingell2,3, Sonia Mirabet Perez3
1Heart Transplant Unit and Pharmacy Department, Hospital de la Santa Creu i Santa Pau, Barcelona, Spain.
Clinical Transplantation
|August 2, 2019
Summary
Heart transplant recipients experience high multimorbidity and therapeutic complexity. The Medication Regimen Complexity Index identifies factors contributing to this complexity, aiding in developing reduction strategies.
Area of Science:
- Cardiology
- Pharmacology
- Transplantation Medicine
Background:
- Multimorbidity and therapeutic complexity are significant challenges in heart transplant (HTx) recipients.
- Quantifying this complexity and identifying reduction strategies remain areas needing further investigation.
Purpose of the Study:
- To assess multimorbidity and medication regimen complexity in adult heart transplant recipients (HTxR) more than 1.5 years post-transplant.
- To identify predictors of medication regimen complexity and its impact on clinical outcomes.
Main Methods:
- Single-center, observational study of 135 chronic-stage HTxR.
- Assessment of multimorbidity (>2 comorbidities) and the patient-level Medication Regimen Complexity Index Spanish version (pMRCI-S).
- Analysis of independent predictors of pMRCI-S and its association with clinical variables.
Main Results:
- Comorbidities significantly increased post-HTx (6±3 vs 2±2).
- HTxR took an average of 12±3 chronic drugs daily, with 58% treating comorbidities.
- Mean pMRCI-S score was 42±11, higher than in other chronic diseases; comorbidity-related medications predicted higher complexity.
- Therapeutic complexity impacted solid malignancies and renal function.
Conclusions:
- Multimorbidity and pMRCI-S scores were notably high in the HTx population.
- The pMRCI score effectively identifies factors driving therapeutic complexity post-HTx.
- This index can guide the selection of strategies to mitigate therapeutic complexity.
Related Concept Videos
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227
01:21Rheumatic Heart Disease III: Medical Management
299
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
299
01:23Inhaled Medications
761
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
761
01:27Anatomy of the Heart
119.4K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.4K
01:18Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
01:14Myocarditis III: Medical Management
182
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
182